Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001757072-25-000004
Filing Date
2025-11-05
Accepted
2025-11-05 20:01:15
Documents
2
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 form3-11062025_011111.html 3  
1 form3-11062025_011111.xml 3 11450
2 ex24-11062025_011111.htm EX-24 6247
  Complete submission text file 0001757072-25-000004.txt   19047
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address
Carver Kyle (Reporting) CIK: 0001757072 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455642

Mailing Address 1841 PAGE MILL RD PALO ALTO CA 94304
Business Address 1841 PAGE MILL RD PALO ALTO CA 94304 (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)